Wespac Advisors, LLC Mckesson Corp Transaction History

Wespac Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$518.81 - $607.81 $535,930 - $627,867	-1,033 Reduced 28.78%	2,556 $1.49 Million
Q1 2024 Apr 24, 2024	BUY	$473.42 - $539.26 $544,906 - $620,688	1,151 Added 47.21%	3,589 $1.93 Million
Q4 2023 Jan 25, 2024	BUY	$437.42 - $470.64 $34,993 - $37,651	80 Added 3.39%	2,438 $1.13 Million
Q3 2023 Oct 25, 2023	BUY	$402.4 - $446.42 $260,352 - $288,833	647 Added 37.81%	2,358 $1.03 Million
Q1 2023 Apr 26, 2023	SELL	$335.35 - $386.06 $215,294 - $247,850	-642 Reduced 27.28%	1,711 $609,000
Q4 2022 Jan 31, 2023	SELL	$346.68 - $397.58 $15,253 - $17,493	-44 Reduced 1.84%	2,353 $882,000
Q3 2022 Oct 18, 2022	BUY	$321.25 - $373.84 $770,036 - $896,094	2,397 New	2,397 $815,000

1,690

109M

1.66M

968K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $90.3B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Wespac Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors, LLC with notifications on news.